X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


最新的帖子

一月 17, 2020

The Latest on Regulations: ICH Guideline to Manage Change throughout the Commercial Lifecycle of Drugs and Combination Products – Part 2

Part 1 of this two part blog series, gave a high-level overview of the new ICH guideline <em>Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management</em>.&nbsp; In part 2 of this blog series, some of the key takeaways will be discussed in more detail.&nbsp; <em>Q12</em> is intended to help companies demonstrate increased product and process knowledge, and understand which post-approval changes will require a regulatory submission, as well as the level of reporting for each category.
Fran DeGrazio

Fran DeGrazio

VP Scientific Affairs and Technical Services

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • 以前的博客
    Zwick/Roell Testing System

    九月 26, 2019

    Performance Testing: Analysis with Zwick/Roell Testing System

    Daniel Bantz

    Daniel Bantz

    Technical Manager, Packaging & Performance Testing

    SmartDose Platform

    六月 27, 2019

    Industry Trends in Biologic Formulations

    Victoria Morgan

    Victoria Morgan

    Director, Segment Marketing, Global Biologics

    Elastomers

    六月 25, 2019

    Bromobutyl versus Chlorobutyl Rubber Formulations - General Aspects

    Heike Kofler

    Dr. Heike Kofler

    Manager, Technical Customer Support Europe

    Load more